Heart Disease and Dental Health: What Townsville Patients Need to Know

Why Cardiac Patients Need to Discuss Their Heart Health With Their Dentist

Cardiovascular disease is Australia’s leading cause of death, affecting approximately 1.2 million Australians. Many Townsville residents manage some form of heart disease — whether coronary artery disease, a history of heart attack, heart failure, valvular disease, or arrhythmia. All of these conditions can affect dental treatment planning, and some dental conditions can affect cardiovascular health.

A dentist who knows a patient’s cardiac history can plan treatment more safely, avoid potential drug interactions, and coordinate with the patient’s cardiologist when needed. Patients should always disclose their full medical history — including cardiac diagnoses and all medications — before dental treatment.

The Gum Disease–Heart Disease Connection

What the evidence shows

Researchers have known for several decades that people with periodontitis (chronic gum disease) have higher rates of cardiovascular disease. The strength and direction of this association have been debated, but recent large-scale studies have strengthened the link.

A meta-analysis by Humphrey et al. (Journal of General Internal Medicine, 2008) pooling data from 1,056,000 subjects found that periodontitis was associated with a 19 per cent increased risk of coronary heart disease. A 2020 European Heart Journal review found associations between periodontitis and hypertension, heart failure, and atrial fibrillation in addition to coronary artery disease.

Proposed mechanisms

Several biological pathways may link periodontal disease to cardiovascular outcomes:

Bacteraemia and systemic inflammation: The gingival tissue in moderate-to-severe periodontitis is essentially a large chronic wound. Routine activities like chewing, brushing, and dental procedures can cause bacteria — particularly Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum — to enter the bloodstream. These bacteria have been found in atherosclerotic plaques. Laboratory studies show they can directly damage arterial endothelial cells.

Systemic inflammatory load: Periodontitis causes elevated systemic inflammatory markers including C-reactive protein (CRP), interleukin-6, and fibrinogen — the same markers associated with increased cardiovascular risk.

Shared risk factors: Smoking, diabetes, obesity, and psychosocial stress all increase risk for both periodontitis and cardiovascular disease. Some of the observed association may reflect these shared pathways rather than a direct causal link.

Clinical implication

The American Heart Association and Australian Heart Foundation do not currently recommend treating gum disease specifically as a cardiac risk reduction strategy — the evidence for treating periodontitis to reduce cardiovascular events is not yet definitive. However, treating periodontitis has well-established benefits for oral health, and for patients with heart disease managing every modifiable risk factor is prudent.

Townsville patients with heart disease and any signs of gum disease — bleeding gums, gum recession, loose teeth, or persistent bad breath — should discuss periodontal assessment with their dentist. See the gum disease treatment guide for more information.

Antibiotic Prophylaxis: Who Needs It and Who Does Not

Current Australian guidelines

The National Heart Foundation of Australia and Australian Dental Association follow the ACC/AHA guidelines in recommending antibiotic prophylaxis before invasive dental procedures for a narrow group of high-risk cardiac patients.

Antibiotic prophylaxis IS recommended for patients with:

Antibiotic prophylaxis is NOT recommended for:

• Coronary artery disease (including past heart attack)
• Stents (coronary or peripheral)
• Hypertension
• Controlled heart failure
• Mitral valve prolapse without regurgitation (updated 2007 AHA guideline)
• Pacemakers and implantable cardioverter-defibrillators
• History of rheumatic fever without residual heart disease
• Most congenital heart defects after complete repair beyond 6 months

This is a common source of confusion — many patients believe any heart condition requires dental antibiotics. The evidence base changed substantially with the 2007 AHA guideline revision, which restricted prophylaxis to high-risk conditions where there is the most evidence that endocarditis prevention is achievable.

What antibiotic is used

The standard regimen is amoxicillin 2g orally, taken 30–60 minutes before the dental procedure. For penicillin-allergic patients, alternatives include clindamycin, azithromycin, or cephalexin.

The antibiotic is taken only on the day of the procedure — not as an ongoing course.

Dental procedures that require prophylaxis (in eligible patients)

Prophylaxis is indicated before procedures that involve manipulation of gingival tissue, the periapical region of teeth, or perforation of the oral mucosa. This includes:

• Tooth extractions
• Periodontal procedures (scaling of deep pockets, surgical treatment)
• Placement of dental implants
• Root canal treatment beyond the apex
• Subgingival placement of retraction cord or antibiotic fibres
• Initial placement of orthodontic bands (not brackets)

It is NOT indicated for:

• Routine anaesthetic injections through non-infected tissue
• Dental x-rays
• Placement and adjustment of removable prostheses or orthodontic appliances
• Shedding of baby teeth

Managing Anticoagulant and Antiplatelet Medications

Many cardiac patients take medications that affect bleeding: warfarin, novel oral anticoagulants (NOACs — rivaroxaban, apixaban, dabigatran), aspirin, or dual antiplatelet therapy (aspirin plus clopidogrel). This is one of the most common concerns patients raise before dental treatment.

Current evidence-based approach

For most dental procedures in most patients, continuing anticoagulation is safer than stopping it. The British Society for Haematology, the Scottish Dental Clinical Effectiveness Programme, and Australian guidance all converge on this position.

The risk of a thromboembolic event (stroke, DVT, pulmonary embolism) if anticoagulation is interrupted typically exceeds the risk of clinically significant bleeding from dental treatment, which can be managed with local haemostatic measures.

Routine dental treatment (no interruption required)

No change to anticoagulants is needed for:

• Examinations and x-rays
• Scale and clean
• Fillings and crowns
• Root canal treatment (single or multi-visit)
• Simple orthodontic adjustments

Extractions and surgical procedures

For warfarin patients, most single and uncomplicated multiple extractions can proceed when INR is within the therapeutic range (typically 2.0–3.5). The dentist should confirm INR is within range with a recent result (ideally within 24–72 hours of the procedure) and apply appropriate local haemostasis: suturing, oxidised cellulose packing, tranexamic acid mouthwash.

For NOAC patients, the half-lives of NOACs are shorter than warfarin and there is no equivalent monitoring test. Current guidance is to proceed with most extractions without stopping NOACs; for more complex surgical procedures, timing the procedure in the trough of the NOAC dosing cycle (the interval before the next dose, typically 6–12 hours after the last dose) provides some reduction in peak anticoagulant effect.

Stopping NOACs or warfarin without medical supervision carries genuine risk. Patients should never stop anticoagulants before dental treatment without explicit instruction from their prescribing doctor.

Aspirin and dual antiplatelet therapy

Aspirin alone rarely causes significant dental bleeding and should not be stopped for routine dental treatment. Dual antiplatelet therapy (aspirin plus clopidogrel, typically used in patients with recent coronary stents) should not be stopped without explicit cardiologist instruction — stopping antiplatelet therapy in patients with recent drug-eluting stents carries a serious risk of stent thrombosis.

Local Anaesthetic in Cardiac Patients

Most dental local anaesthetics contain a vasoconstrictor — usually adrenaline (epinephrine) — to prolong and intensify the anaesthetic effect and reduce systemic absorption. The adrenaline concentration in standard dental cartridges is 1:100,000 (approximately 18 micrograms per 1.8 mL cartridge).

Is adrenaline-containing local anaesthetic safe for cardiac patients?

For most cardiac patients: yes. The cardiovascular effects of 1–2 dental cartridges of local anaesthetic with 1:100,000 adrenaline are minimal and well within the range of what a healthy heart or well-managed cardiac condition can tolerate.

Higher caution is warranted for:

• Unstable angina or recent myocardial infarction (within 3 months) — defer elective treatment
• Severe uncontrolled hypertension (systolic BP above 180) — defer elective treatment until controlled
• Recent coronary artery bypass surgery or valve surgery (within 3 months) — defer elective treatment
• Patients with catecholamine hypersensitivity states (very rare)

For most patients with controlled hypertension, coronary artery disease, stable heart failure, or history of angioplasty and stenting, standard local anaesthetic with adrenaline is appropriate. The anxiety and pain of undertreated dental pain is a greater cardiovascular stressor than a small dose of adrenaline.

Adrenaline-free local anaesthetic (mepivacaine or prilocaine without vasoconstrictor) is available and can be used in patients where adrenaline is a genuine concern, though the duration of anaesthesia is shorter.

Practical Advice for Townsville Cardiac Patients

Tell your dentist your full cardiac history at every new patient appointment. Include diagnoses, procedures (including stents, valves, pacemakers), and all medications. A change in cardiac status since the last visit should also be communicated.

Bring a current medication list. Drug interactions between dental anaesthetics, analgesics, and antibiotics with cardiac medications can be significant. NSAIDs interact with warfarin and antihypertensives. Erythromycin and clarithromycin (sometimes used as antibiotic prophylaxis alternatives) interact with statins. A complete medication list allows the dentist to check interactions safely.

Do not avoid dental care out of cardiac concern. Untreated dental infection and periodontal disease pose their own cardiac risks. The evidence strongly supports that most dental treatment can be safely carried out in cardiac patients with appropriate planning.

Schedule morning appointments. Cardiovascular events follow a circadian pattern with a peak in the early-morning hours. Dental appointments later in the morning (9:30–11:00 am) when the patient is rested and any morning medications have had time to act are often recommended for high-risk cardiac patients.

Do not drive after IV sedation. Patients who require IV sedation for dental treatment and take cardiac medications affecting the central nervous system should arrange a responsible adult to drive them home.

For more information on dental care with complex medical conditions, see the diabetic dental care Townsville guide and the dental anxiety and sedation guide.